Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
85.65%
↑ 72% above average
Average (39q)
49.75%
Historical baseline
Range
High:1144.63%
Low:-86.35%
Volatility
2474.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 85.65% |
| Q2 2025 | 22.13% |
| Q1 2025 | -84.20% |
| Q4 2024 | 111.94% |
| Q3 2024 | 57.12% |
| Q2 2024 | 15.35% |
| Q1 2024 | -86.35% |
| Q4 2023 | 89.29% |
| Q3 2023 | 396.63% |
| Q2 2023 | -26.07% |
| Q1 2023 | -67.39% |
| Q4 2022 | -59.23% |
| Q3 2022 | 1144.63% |
| Q2 2022 | 5.16% |
| Q1 2022 | -3.20% |
| Q4 2021 | -9.52% |
| Q3 2021 | -9.05% |
| Q2 2021 | 2.64% |
| Q1 2021 | 12.47% |
| Q4 2020 | 9.04% |
| Q3 2020 | -29.18% |
| Q2 2020 | 45.42% |
| Q1 2020 | 28.49% |
| Q4 2019 | 11.39% |
| Q3 2019 | -83.24% |
| Q2 2019 | 16.35% |
| Q1 2019 | 37.39% |
| Q4 2018 | 125.37% |
| Q3 2018 | -55.71% |
| Q2 2018 | 228.80% |
| Q1 2018 | 11.91% |
| Q4 2017 | 46.05% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |